跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SIBNAYAL 8 MEQ GRANULOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SIBNAYAL 8 MEQ GRANULOS DE LIBERACION PROLONGADA
Approved
STANDARD
SIBNAYAL 8 MEQ GRANULOS DE LIBERACION PROLONGADA
Advicenne
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2023
Approval ID
7227391aa073c214
Company
Advicenne
Type
Standard
Approval Details
Approval Id
7227391aa073c214
Drug Cima Aemps Name
SIBNAYAL 8 MEQ GRANULOS DE LIBERACION PROLONGADA
Register Number
1201517001
Holder Company Name
Advicenne
Marketing Company Name
Spa Farma Iberica S.L.
Holder Company Detail Path
/organization/advicenne
Authorization Date
2023-05-09
Dosage Form
GRANULADO DE LIBERACIÓN PROLONGADA
Dose
8 mEq
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Advicenne
Company Detail Path
/organization/advicenne
Company Information
Pharmaceutical Company Name
ADVICENNE
Country Name
France
City Name
paris 2 e arrondissement,ile-de-france,country_fr
Address
ADVICENNE PHARMA ADVICENNE
Active Ingredients
CITRATO POTASIO
282,19 mg
POTASIO BICARBONATO
527,19 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2023
Approval ID
7227391aa073c214
Type
Standard
Back to CIMA-AEMPS Approvals
